<i>PALB2</i>, <i>CHEK2</i> and <i>ATM</i> rare variants and cancer risk: data from COGSMelissa C. Southey, Heli Nevanlinna, John L. Hopper et al.|Journal of Medical Genetics|2016Cited by 217
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort studyRenée Schmitz, Marjanka K. Schmidt, Alexandra W. van den Belt‐Dusebout et al.|BMJ|2023Cited by 44
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association ConsortiumDieter Flesch‐Janys, Jieping Lei, Anja Rudolph et al.|Human Genetics|2015Cited by 10
DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCISEllen G. Engelhardt, Lotte Elshof, Renée Schmitz et al.|The Breast|2024Cited by 1
Abstract P1-22-02: Subsequent risk of ipsilateral breast events in a multinational DCIS cohort of 48.619 patients: A meta-analysis within the PRECISION consortiumRenée Schmitz, Marjanka K. Schmidt, Sandra W van den Belt-Dusebout et al.|Cancer Research|2022Cited by 0